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Background
Glycogen storage diseases (GSD) are a group of inherited
disorders of carbohydrate metabolism that occur in
humans and animals. Variants in 20 different genes are
currently known to result in GSD in humans.1 One of the
candidate genes is G6PC1 encoding glucose-6-phosphatase
catalytic subunit 1. G6PC1 loss-of-function variants cause
GSD1A, which is also termed von Gierke disease. The dis-
ease is characterized by severe hypoglycemia and hep-
atomegaly owing to hepatic glycogen accumulation early
in life.2 A canine form of GSD1A has been identified in
Maltese Terriers and is caused by a p.Met121Ile variant in
the G6PC1 gene (OMIA 000418-9615).3 Dogs with
GSD1A have become a popular, naturally occurring ani-
mal model for gene-therapy research in this disease.3-5
Analyses
Two 4-week-old purebred German Pinscher puppies, one
male and one female, showed an enlarged abdomen at
clinical examination and poor weight gain since birth.
Ultrasonography of the female puppy revealed an increased
liver size. Furthermore, this puppy was reported to be bilat-
erally blind. The male puppy developed seizures. The
affected puppies were euthanized owing to worsening of
clinical signs and poor prognosis. At necropsy, both dogs
showed severe hepatomegaly with light brown to yellow
discoloration and fragile consistency of the liver. Histologi-
cally, diffuse swelling and vacuolization of hepatocytes
with peripheral displacement of nuclei was found. Periodic
acid Schiff-positive, diastase-sensitive material was present
in hepatocytes, indicating glycogen accumulation.
We isolated genomic DNA from both cases from liver
tissue samples and sequenced the genome of one affected
dog at approximately 18.69 coverage with Illumina
2 9 150 bp reads. The data were analyzed as described
previously6 and submitted to the European Nucleotide
Archive under sample accession no. SAMEA8157169. Fil-
tering for variants present only in the sequenced dog and
absent in 795 control genomes (Table S1) yielded no
homozygous private protein-changing variant in a known
GSD candidate gene1 (Table S2).
We then visually inspected the short read alignments in
the candidate genes for structural variants using the Inte-
grative Genomics Viewer.7 This revealed a homozygous 76
bp insertion into exon 5 of the G6PC1 candidate gene,
which probably causes a loss of function (chr9:
g.20,134,857_20,134,858ins76; XM_038676372.1:c.634_
635ins76). The insertion consisted of 60 consecutive adeni-
nes and an additional 16 bp duplication of the integration
site (Figure 1, File S1). The variant was confirmed by
Figure 1 Insertion into exon 5 of the G6PC1 gene. (a) Integrative Genomics Viewer screenshot illustrating the structural variant in the orientation
of the CanFam 3.1 genome reference sequence. The case shows an increased coverage over 16 nucleotides characteristic for the duplication of
sequences at transposable element integration sites spanning Chr9:20,134,842–20,134,857 (CanFam3.1 assembly). Soft-clipped bases deviating
from the genome reference to the left and the right side of this duplication appear bright red owing to the presence of poly-T stretches. Colored
reads indicate that their mates map to other chromosomes. These features are characteristic of an insertion of a repetitive element into the gen-
ome of the affected dog. (b) Schematic representation of the insertion into the last exon of the G6PC1 gene. As G6PC1 is in reverse complemen-
tary orientation with respect to the genome reference, the insertion is now represented as a poly-A stretch. (c) Fragment size analysis of the PCR
amplification products obtained from genomic DNA with primers 50-GCATGCAATGGGAGAATGTA-30 and 50-AGGTGCAGGAGGATGAGAGA-30.
Representative results of an affected dog (ins/ins), heterozygous carrier (wt/ins) and a healthy control (wt/wt) are shown. The samples were
analyzed on a 5200 FragmentAnalyzer capillary gel electrophoresis instrument (Agilent). In the carrier dog, the two minor bands that migrated
more slowly than the two main products most likely represent heteroduplex molecules consisting of one mutant and one wt strand.
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Sanger sequencing and an additional 208 unrelated Ger-
man Pinscher dogs were genotyped. Only the two affected
dogs carried the insertion in a homozygous state. However,
24 additional heterozygous carriers were identified corre-
sponding to a carrier frequency of 12%.
Conclusions
Based on the clinical and histological findings GSD was
diagnosed in two German Pinscher puppies. A precision
medicine approach identified a 76 bp SINE insertion in
G6PC1 as the most likely candidate causative variant and
allowed designation of the phenotype as GSD1A. The dis-
ease allele is present at non-negligible frequency in the
German Pinscher dog population and the introduction of
genetic testing for breeding animals is recommended.
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